Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Gross Profit (2020 - 2025)

Rapid Micro Biosystems' Gross Profit history spans 6 years, with the latest figure at $4.9 million for Q3 2025.

  • For Q3 2025, Gross Profit rose 16.91% year-over-year to $4.9 million; the TTM value through Sep 2025 reached $18.8 million, up 47.59%, while the annual FY2024 figure was $14.8 million, 60.76% up from the prior year.
  • Gross Profit for Q3 2025 was $4.9 million at Rapid Micro Biosystems, up from $4.1 million in the prior quarter.
  • Across five years, Gross Profit topped out at $5.2 million in Q4 2024 and bottomed at $250000.0 in Q4 2022.
  • The 5-year median for Gross Profit is $2.7 million (2021), against an average of $2.7 million.
  • The largest annual shift saw Gross Profit plummeted 87.5% in 2022 before it surged 1170.4% in 2023.
  • A 5-year view of Gross Profit shows it stood at $1.9 million in 2021, then plummeted by 86.51% to $250000.0 in 2022, then soared by 1170.4% to $3.2 million in 2023, then surged by 64.86% to $5.2 million in 2024, then decreased by 5.6% to $4.9 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Gross Profit are $4.9 million (Q3 2025), $4.1 million (Q2 2025), and $4.5 million (Q1 2025).